Blue et al. (Obstetrics & Gynecology, 2018) compared the efficacy of these two methods of predicting small for gestational age (SGA) birth
Retrospective Review (2013-2017)
Included mothers with singleton, well-dated pregnancies and noanomalous fetuses
Indicated fetal growth restriction surveillance
Ultrasound-estimated fetal weight within 30 days of delivery
Hadlock intrauterine growth curve
Small for gestational age (SGA): Birth weight <10th percentile based on a recent, sex-specific curve
Area under the curve (AUC), sensitivity, specificity, and positive and negative likelihood ratios were calculated
DeLong analysis used to determine significance, rather than overlapping CIs
1,704 pregnancies were included
235 (13.8%) of pregnancies results in SGA
Rate of fetal growth restriction differed between the two guidelines (P=.007)
RCOG’s diagnostic approach had a significantly higher area under the curve (P=.01)
RCOG: 0.78 (95% CI 0.76–0.80)
ACOG: 0.76 (95% CI 0.74–0.78)
Sensitivities and specificities of the various methods were similar
Adopting estimated fetal weight or abdominal circumference less than the 10th percentile instead of estimated fetal weight alone to predict SGA at birth would correctly identify one additional case of SGA for each 14 patients assessed
The guidelines introduced by RCOG are better in predicting SGA, although not by a large margin
Benefit of better prediction is the identification of fetuses at risk for stillbirth
This study does not address outcomes and would require a larger, prospective study, including determining whether newborns are truly smaller than their potential or are simply constitutionally small
Please sign up or log in to your ObGFirst to access this Premium Content
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan